Published in Hepatitis Weekly, October 27th, 2008
"Prophylaxis for reinfection was performed with a combination of lamivudine, or hepatitis B Immune globulin (HBIG) or adefovir, depending on the viral status. The changes in serological markers, recurrence and survival rate were examined. There were 3 patients with re-emergencies of HBV surface antigen (HBsAg): suspension of HBIG for giving...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.